Axogen Inc (AXGN) Stock Price Today
Analysts raise bullish targets for ServiceNow despite recent stock volatility.
Several top analysts, including Cantor Fitzgerald, Guggenheim, Morgan Stanley, and BTIG Research, have raised price targets and upgraded their outlooks for ServiceNow, signaling confidence in the company's long-term growth. Despite this, the stock ha...
Colgate-Palmolive cuts price target amid North America challenges, plans growth via premium products and brand sales.
Piper Sandler lowered Colgate-Palmolive's price target to $95 due to weak North American demand and rising competition. The company is responding by focusing on premium oral care innovations, expanding the Fabuloso line, increasing advertising, and c...
Microsoft's price target raised to $440 amid strong 2026 financials, but stock trades above target at $493.78.
Rothschild & Co Redburn raised Microsoft's price target from $400 to $440 following strong fiscal 2026 results, with revenue up 18% to $331.8 billion and net income rising 31% to $133.7 billion, driven by cloud and AI demand. Despite the target hike,...
Accenture stock drops 4.73% amid concerns over valuation and weak demand trends
Accenture's stock fell 4.73% to $181.29 after Guggenheim reiterated a Neutral rating, citing that the stock price has outpaced the company's actual business performance. Analysts point to weak customer demand, fewer job postings, and a cautious mid-m...
Thryv CEO buys shares amid shift to digital, selling print business for $142M
Thryv Holdings is selling its traditional print directory business for $142 million to focus on business automation software for small and medium businesses. CEO Walsh Joe bought 25,000 shares at $1.80 each, increasing his stake to 788,099 shares, si...
Study confirms First Phosphate's Bégin-Lamarche deposit as high-purity source for battery-grade phosphoric acid.
A peer-reviewed study published in Ore Geology Reviews has validated First Phosphate Corp.'s Bégin-Lamarche deposit as a promising source of high-purity phosphate suitable for producing battery-grade phosphoric acid. The deposit features phosphate-ri...
Medicus Pharma narrows SkinJect trials to Gorlin syndrome after FDA feedback
Medicus Pharma will focus its SkinJect clinical development exclusively on patients with Gorlin syndrome, a rare disease causing multiple basal cell carcinoma lesions, and will stop development for sporadic basal cell carcinoma. This decision follows...
Apple at $336 is strong but pricey, with growth and cash offset by high valuation risks.
Apple's stock at $336 reflects strong fundamentals including nine consecutive earnings beats, 16.4% revenue growth, and a $147 billion cash reserve. Despite this, the stock trades at a high valuation with a trailing P/E of 44, which is steep for a ha...
PepsiCo shares fall 7% YTD but BNP Paribas targets 41% gains on strong international growth.
PepsiCo shares have dropped nearly 7% this year, underperforming the S&P 500's double-digit gains, mainly due to weaker North American sales and consumer pressures. Despite this, BNP Paribas Exane maintains a bullish $183 price target, implying a 41%...
Bitcoin and Grayscale Bitcoin Mini Trust ETF maintain buy rating after 45% Q3 surge and strong technical signals.
Bitcoin and the Grayscale Bitcoin Mini Trust ETF (BTC) continue to hold a buy rating following a 45% price surge in Q3 and positive technical indicators such as a bullish cup and handle breakout, rising 200-day moving average, and a golden cross patt...
All investments involve risks and the possibility of a loss in investment value. Past performance is not indicative of future results. Historical performance, expected returns, and probability projections are provided for informational and illustrative purposes only.